rs115398036
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000375985.5(MYLK2):c.266G>A(p.Gly89Asp) variant causes a missense change. The variant allele was found at a frequency of 0.00229 in 1,612,926 control chromosomes in the GnomAD database, including 67 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G89C) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000375985.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYLK2 | NM_033118.4 | c.266G>A | p.Gly89Asp | missense_variant | 3/13 | ENST00000375985.5 | NP_149109.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYLK2 | ENST00000375985.5 | c.266G>A | p.Gly89Asp | missense_variant | 3/13 | 1 | NM_033118.4 | ENSP00000365152 | P1 | |
MYLK2 | ENST00000375994.6 | c.266G>A | p.Gly89Asp | missense_variant | 2/12 | 1 | ENSP00000365162 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0125 AC: 1904AN: 152230Hom.: 36 Cov.: 32
GnomAD3 exomes AF: 0.00317 AC: 783AN: 246836Hom.: 14 AF XY: 0.00226 AC XY: 304AN XY: 134392
GnomAD4 exome AF: 0.00122 AC: 1786AN: 1460578Hom.: 31 Cov.: 32 AF XY: 0.00103 AC XY: 751AN XY: 726574
GnomAD4 genome AF: 0.0125 AC: 1908AN: 152348Hom.: 36 Cov.: 32 AF XY: 0.0119 AC XY: 890AN XY: 74492
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 02, 2012 | Gly89Asp in exon 3 of MYLK2: This variant is not expected to have clinical signi ficance because it has been identified in 3.9% (146/3716) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs115398036). - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 13, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Hypertrophic cardiomyopathy 1 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 20, 2020 | - - |
Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jan 18, 2016 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hypertrophic cardiomyopathy Benign:1
Benign, no assertion criteria provided | research | Zaffran Lab, Genetics of Cardiac Diseases Laboratory, Marseille Medical Genetics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at